Bio-Connect
ICC/IF analysis of Hep3B cells using GTX57657 GALE antibody. Blue: DAPI Green: Primary antibody Dilution: 1:100
ICC/IF analysis of Hep3B cells using GTX57657 GALE antibody. Blue: DAPI Green: Primary antibody Dilution: 1:100
ICC/IF analysis of Hep3B cells using GTX57657 GALE antibody. Blue: DAPI Green: Primary antibody Dilution: 1:100

GALE antibody [AT6G10]

GTX57657
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman
TargetGALE
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    GALE antibody [AT6G10]
  • Delivery Days Customer
    9
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    AT6G10
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID2582
  • Target name
    GALE
  • Target description
    UDP-galactose-4-epimerase
  • Target synonyms
    epididymis secretory sperm binding protein; galactose-4-epimerase, UDP-; galactowaldenase; SDR1E1; short chain dehydrogenase/reductase family 1E, member 1; UDP galactose-4'-epimerase; UDP-GalNAc 4-epimerase; UDP-GlcNAc 4-epimerase; UDP-glucose 4-epimerase; UDP-N-acetylgalactosamine 4-epimerase; UDP-N-acetylglucosamine 4-epimerase
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDQ14376
  • Protein Name
    UDP-glucose 4-epimerase
  • Scientific Description
    This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and cognitive disability, with symptoms ranging from mild (peripheral form) to severe (generalized form). Multiple alternatively spliced transcripts encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203